Physician profile
Yoshinobu Mifune
NPI 1902896525
$1,861.78
in general payments reported to CMS, 2019-2025
18 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Undersea and Hyperbaric Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $168 · 2021: $292 · 2022: $180 · 2023: $86.99 · 2024: $240 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $729.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $538.62 | 2019-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $284.68 | 2019-2025 | Apligraf |
| Smith+Nephew, INC. | $258.20 | 2019-2025 | Grafix, Pico 14, Collagenase Santyl |
| Kerecis Limited | $177.65 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $114.29 | 2021-2023 | |
| Derma Sciences, INC. | $108.89 | 2019 | |
| Paratek Pharmaceuticals, INC. | $91.54 | 2020-2025 | Nuzyra |
| Amniox Medical, INC. | $44.09 | 2019-2020 | |
| Reapplix INC. | $36.16 | 2023 | 3c Patch Kit - Box |
| Tactile Systems Technology INC | $32.32 | 2019 | |
| Kci USA, INC. | $32.26 | 2022 | |
| Medline Industries Lp | $26.65 | 2019 | |
| Lifenet Health | $23.20 | 2024 | Theragenesis Wound Matrix |
| Acera Surgical, INC. | $21.97 | 2025 | Restrata Wound Matrix |
| Misonix INC | $21.49 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $20.18 | 2021 | |
| Mimedx Group, INC. | $18.27 | 2025 | |
| Allergan, INC. | $11.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoshinobu Mifune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.